home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

webinar on FDA’s “483” – Inspectional Observations by global compliance trainings

 
  February 27, 2014  
     
 
Global Compliance Trainings, 201,N Squirrel road, Suite 1007, Auburn Hills, Michigan United States - 48326.
10-03-2014


Webinar Description :


At the end of FDA’s establishment inspection, the investigator makes “observations” of instances where it appears the firm does not conform to a regulatory requirement. You are warned that if you do not correct the problems, FDA may take further legal action. How you respond to FDA from that point on plays a critical role in your future with FDA. Inspectional observations show what problems you have had in the past, where you still have problems and whether or not you know how to effectively respond to inspectional observations. In FDA’s mind, the question is, “Do you get it?”
 

Why you should attend: 

During an inspection, FDA makes a list of things that do not appear to conform to a regulatory requirement.  FDA calls them “observations” and lists them on Form FDA 483, referred to as the “483.”  At a minimum, inspectional observations tell a firm where it seems to have particular problems.  The problems typically are much more systemic than just the particular observations.

As you read a 483, you begin to see a picture of how the firm stacks up against FDA’s expectations.  Responding efficiently and effectively to 483 observations plays a critical role in how a firm can work out its problems with FDA.  A failure to respond adequately to a 483 can become a short road into a deep FDA regulatory swamp.  You need to know how to avoid FDA’s regulatory swamp.

Objectives of the Presentation:

·       FDA 483 inspectional observation format

·       How inspectional observations are ranked in importance

·       How you can respond to observations during an inspection

·       How to respond to a Form FDA 483 after an inspection

·       Planning and implementing a corrective action

·       How to work with FDA, not around it

Who will benefit: 

·       Regulatory affairs professionals

·       Manufacturing and Quality Assurance managers

·       FDA consultants

·       In-house legal counsel

·       Marketing managers

·       Executive and finance executives

 

Why you should attend: 

During an inspection, FDA makes a list of things that do not appear to conform to a regulatory requirement.  FDA calls them “observations” and lists them on Form FDA 483, referred to as the “483.”  At a minimum, inspectional observations tell a firm where it seems to have particular problems.  The problems typically are much more systemic than just the particular observations.

As you read a 483, you begin to see a picture of how the firm stacks up against FDA’s expectations.  Responding efficiently and effectively to 483 observations plays a critical role in how a firm can work out its problems with FDA.  A failure to respond adequately to a 483 can become a short road into a deep FDA regulatory swamp.  You need to know how to avoid FDA’s regulatory swamp.

Instructor Profile
Casper Uldriks brings over 32 years of experience from the FDA. He specialized in the FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions, participated in the implementation of new statutory requirements. He is recognized as an exceptional and energetic speaker. His comments are candid, straight forward and of practical value. He understands how FDA thinks, operates and where it is headed. Cap now works almost exclusively on medical device issues at Olsson, Frank, and Weeda (OFW Law in Washington, D.C.)
 

Live Session for one participant

Price: $225.00

 

Bottom of Form

Top of Form

Corporate Live Session 4 to 10 participants in single location.

Price:$885.00

 

Bottom of Form

Top of Form

Recorded Session Access recorded sessions only for one participant unlimited viewing for 6 months.

Price: $275.00


 
 
 
Organized by: Global Compliance Trainings
Invited Speakers:

 

 

 

 

 

   Casper Uldriks

 
Deadline for Abstracts: 10th March 2014
 
Registration:

 

 

  10th March 2014

E-mail: webinar@globalcompliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.